This Study Observes the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Elderly Patients With a Heart Rhythm Disorder in Spain

Boehringer Ingelheim

Status: Completed

Conditions: Atrial Fibrillation

Treatments: Drug: Non-vitamin K antagonist oral anticoagulant

Study type: Observational

Funder types: Industry

Identifiers

NCT03993119

1160-0297

Details and patient eligibility

About

This is an observational, multicenter and cross-sectional study in Non-valvular atrial fibrillation (NVAF) elderly patients currently on Non-vitamin K antagonist oral anticoagulant (NOAC) treatment for their stroke prevention.

Enrollment: 500 patients

Sex: All

Ages: 75+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients are willing and provide written informed consent prior to participate in this study
• Patients ≥ 75 years-old at the time of the study visit.
• Patients with a diagnosis of non-valvular atrial fibrillation (NVAF).
• Patients who are being treated with NOAC treatment according to the indication approved in the Summary of Product Characteristics (SmPC).
• Patients who have started the NOAC treatment at least 3 months prior to the study visit.

Exclusion criteria

Patients will be excluded from participating in this study if the following criterion is met:

• Current participation in any clinical trial of a drug or device.
• Patients who have any contraindication for NOAC treatment, according to the SmPC.

Trial design

500 participants in 1 patient group

patients with NVAF

Treatment:

Drug: Non-vitamin K antagonist oral anticoagulant